Oxygen Therapy Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Staionary,Portable), By Application (Hospital,Clinic,Home Care,Others), Regional Insights and Forecast to 2035

Oxygen Therapy Equipment Market Overview

The global Oxygen Therapy Equipment Market size is projected to grow from USD 3240.48 million in 2026 to USD 3467.32 million in 2027, reaching USD 5957.45 million by 2035, expanding at a CAGR of 7% during the forecast period.

The Oxygen Therapy Equipment Market is characterized by deployment of devices such as oxygen concentrators, liquid oxygen units, compressed oxygen cylinders, masks, cannulas, and delivery devices. In 2024, the oxygen source equipment segment accounted for roughly 54.3 % share of the oxygen therapy equipment market. The stationary devices segment held approximately 70.2 % share (based on portability data). The COPD (chronic obstructive pulmonary disease) application segment represented 28.7 % share in 2024. The North American region commanded around 40.2 % share of the global oxygen therapy equipment market in 2024. Tier 1 players hold about 55.5 % of the overall market share among global participants.

In the United States specifically, the U.S. Oxygen Therapy Equipment Market generated about USD 9,208.3 million in 2022 and accounted for 26.7 % of the global oxygen therapy market share. Oxygen source equipment emerged as the largest product segment in that year, while oxygen delivery devices registered the fastest growth trend. The U.S. share in the global market is projected to remain leading in coming years. As of 2024, fixed concentrators held around 46.8 % share of the U.S. concentrator segment, and continuous flow technology devices made up 56.03 % share in that segment. The U.S. market is thus central in any Oxygen Therapy Equipment Market Report and Oxygen Therapy Equipment Market Analysis.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 54.3 % of the Oxygen Therapy Equipment Market demand is driven by oxygen source equipment adoption, while 38.42 % of respiratory therapy demand is linked to COPD prevalence. Approximately 56.03 % of devices use continuous flow technology and about 41.37 % of end users prefer homecare-based oxygen therapy systems.
• Major Market Restraint: 70.2 % of oxygen therapy equipment usage is concentrated in stationary devices, creating mobility limitations for patients. Around 20–30 % of potential patients in emerging regions face affordability barriers, while penetration rates remain below 5 units per 1,000 population in several developing healthcare systems.
• Emerging Trends: 28.7 % of oxygen therapy equipment demand originates from COPD applications, while portable oxygen concentrators represent 38.6 % of the global device base. Around 15–20 % of newly introduced devices include IoT monitoring capabilities, and 20–25 smart oxygen therapy models were launched globally between 2023 and 2025.
• Regional Leadership: 40.2 % of the Oxygen Therapy Equipment Market share is held by North America, with the United States contributing about 26.7 % of global market presence. Approximately 46.8 % of U.S. concentrator installations consist of fixed concentrators, while 56.03 % of devices operate with continuous flow oxygen delivery.
• Competitive Landscape: 55.5 % of the Oxygen Therapy Equipment Market is controlled by Tier-1 manufacturers, while approximately 18–21 % share is held by the largest company and 13–15 % share by the second-largest supplier. Around 30 major companies collectively account for more than 70 % of global product shipments.
• Market Segmentation: 65.35 % of the Oxygen Therapy Equipment Market segmentation is attributed to oxygen source equipment products. Stationary systems account for about 53.82 % to 70.2 % of installations, while portable oxygen devices contribute roughly 38.6 % of the total device distribution across healthcare settings.
• Recent Development: 18–21 % of new oxygen therapy equipment product launches occurred between 2023 and 2025, including more than 60 device innovations focused on concentrator efficiency. Approximately 15–20 % of newly launched models incorporate digital connectivity and remote monitoring technologies.

Oxygen Therapy Equipment Market Latest Trends

In current Oxygen Therapy Equipment Market Trends, portable and smart devices are rapidly gaining traction. Portable oxygen concentrators now hold a share of 38.6 % of the total device base, reflecting growing preference for mobility and convenience. Innovations such as real-time SpO₂ (oxygen saturation) monitoring, Bluetooth connectivity, and IoT integration are present in about 20–25 models introduced globally in 2023–2025. The oxygen source equipment segment continues to dominate with approximately 54–65 % share across global markets, especially via concentrators and liquid oxygen systems. In one trend, stationary devices still account for 70.2 % share, but portable devices are steadily expanding in usage. In hospital settings, over 60 device launches in 2023 centered on concentrator efficiency and quieter operation. Among emerging innovations, devices enabling user compliance tracking and app-based management feature in 15–20 % of new units. Oxygen Therapy Equipment Market Outlook increasingly emphasizes hybrid models combining stationary and portable features; for example, dual mode concentrators emerged in 12 product lines in 2024. Adoption in home care is rising: homecare end users had over 41.37 % share in hospital vs home breakdown in 2024. Overall, Oxygen Therapy Equipment Market Trends are shifting toward patient-centric, connected, and mobile solutions, driving growth in the Oxygen Therapy Equipment Market Report and Oxygen Therapy Equipment Market Forecast narratives.

Oxygen Therapy Equipment Market Dynamics

DRIVER

"Rising prevalence of respiratory disorders"

One major growth driver is the increasing global prevalence of respiratory illnesses. In 2023, COPD accounted for 38.42 % of the oxygen therapy equipment market by application segment. The WHO estimates that approximately 200 million people suffer from COPD globally. In the U.S., over 34 million residents live with chronic lung diseases such as COPD and asthma, fueling demand for oxygen delivery systems. The aging population also contributes: in the U.S. in 2024, 17.3 % of the population (about 57.8 million) were aged 65+, many of whom require long-term oxygen therapy. These demographic and disease burdens drive need for home oxygen systems, boosting purchase of concentrators and cylinders. The Oxygen Therapy Equipment Market Report often cites these disease incidence and population figures as the core rationale behind expansion in both hospital and home care settings. The oxygen source equipment segment captured 65.35 % share in 2024 in some analyses, indicating that devices supplying oxygen remain foundational to market structure.

RESTRAINT

"High cost of equipment and maintenance"

A primary restraint is the elevated upfront and operational costs associated with oxygen therapy systems. Many devices require specialized components, replacement parts, filters, and servicing. In emerging markets, purchase and maintenance costs restrict accessibility; in some low-income regions, only 10–20 % of potential patients can afford new units. Regulatory compliance and certification costs further drive business expenses. Also, availability of refurbished or used equipment competes on price but comes with quality uncertainty, limiting adoption in quality-sensitive hospital settings. The installed base in several developing nations remains low – penetration rates in Africa and parts of Asia often remain below 5 units per 1,000 population. These cost and access challenges restrain aggressive expansion in certain geographies, slowing the forecasted growth in parts of the Oxygen Therapy Equipment Market Outlook.

OPPORTUNITY

"Expansion of home healthcare and remote monitoring"

Substantial opportunity exists in the shift to home care and connected devices. In 2024, homecare solutions captured over 41.37 % of end-user share versus hospitals in some data sets. With healthcare systems pushing for outpatient management, demand for compact, efficient portable concentrators is rising. Remote monitoring features SpO₂ data, usage logs, alerts are incorporated in about 15–20 % of new models as standard. Territories with low current penetration but rising healthcare expenditure, such as India, China, and Latin America, offer prime expansion opportunities. In Asia-Pacific, the oxygen therapy equipment regionally held 930.7 million USD share in 2024 (per one dataset). Further, partnerships between device manufacturers and telehealth providers have launched in 8–10 countries in 2023–2025 to bundle oxygen therapy with remote care services. Such integrations are catalyzing interest in the Oxygen Therapy Equipment Market Growth narrative and are core to Oxygen Therapy Equipment Market Opportunities discussions.

CHALLENGE

"Supply chain disruptions and regulatory barriers"

A pressing challenge is component shortages and supply chain fragility. Many devices rely on specialized membrane materials, sensors, and battery technologies. Delays in semiconductor or filter supply can delay production by 3–6 months. Regulatory hurdles present another challenge: approval times for medical certification vary widely some markets require 12–18 months per model. Variability in reimbursement policies across geographies complicates market entry: in some countries, oxygen therapy is reimbursed at 20–50 % coverage only in limited indications. Clinical trials, safety validations, and local certification can require additional capital. Any recall or performance failure like the 2024 recall of respiratory SKUs by a major manufacturer can render extensive portfolio gaps. These challenges hinder swift scaling and are often emphasized in the Oxygen Therapy Equipment Industry Report and Oxygen Therapy Equipment Market Risk sections.

Oxygen Therapy Equipment Market Segmentation

The Oxygen Therapy Equipment Market is segmented primarily by type and application. The type segmentation includes Hospital, Clinic, Home Care, and Others. The application segmentation consists of Stationary and Portable modes of operation. In the Oxygen Therapy Equipment Market Analysis, this taxonomy helps dissect demand sources by care setting and device mobility. Hospital and clinic types emphasize high-capacity stationary systems, while home care and others (e.g. ambulances, field clinics) increasingly use portable models. In applications, stationary units serve >50 % share in 2024 while portable units are rising (≈ 38.6 % share). The segmentation is central to many Oxygen Therapy Equipment Market Reports and Oxygen Therapy Equipment Market Forecasts for pricing, adoption, and regional nuance.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Hospital: Hospital settings use high-capacity oxygen therapy systems, such as liquid oxygen storage, bulk concentrators, and centralized piping delivery systems. These hospital installations typically account for the largest capital orders often 30–40 units per hospital chain in larger markets. In the U.S., hospitals order portfolios of 5–10 large stationary concentrators per site. In Europe, large health systems allocate 10–15 % of their respiratory device procurement budgets to oxygen therapy equipment. Hospitals also require advanced monitoring, backup systems, and integration with electronic health records, driving demand for higher-end devices. This makes the hospital segment a stable but highly demanding buyer group in Oxygen Therapy Equipment Market Reports.

The Hospital segment is estimated at USD 1,210.4 million in 2025, projected to reach USD 2,160.8 million by 2034, expanding at a CAGR of 6.9%, representing approximately 40% of the total market share.

Top 5 Major Dominant Countries in the Hospital Segment

• United States: Leads with an estimated market size of USD 490.2 million in 2025, holding a 40.5% share and growing at a CAGR of 6.8% due to advanced healthcare infrastructure.
• Germany: Valued at USD 145.8 million in 2025, with a 12.1% share and a CAGR of 6.7%, supported by a high adoption rate in critical care units.
• Japan: Holds USD 132.5 million in 2025, accounting for 10.9% share and expanding at 6.9% CAGR fueled by aging demographics and high hospital admissions.
• China: Estimated at USD 128.7 million in 2025, with 10.6% share and 7.2% CAGR, driven by growing healthcare expenditure and government initiatives.
• United Kingdom: With USD 98.3 million in 2025, a 8.1% share, and 6.5% CAGR, growth is attributed to expanding intensive care facilities.

Clinic: Clinics and outpatient centers invest in mid-scale units. The clinic segment typically purchases stationary concentrators (1–3 units) or backup compressed cylinders. In Germany and France, 20–30 % of clinics now include oxygen therapy rooms. The clinic segment often adopts intermediate models with moderate portability to serve patient visits and minor emergencies. These clinics may replace cylinder stock with small concentrators to reduce logistic costs. In B2B sales, clinic procurement tends to focus on compact, low-noise units with moderate throughput (2–5 liters per minute), making this a niche but growing type in Oxygen Therapy Equipment Market Analysis.

The Clinic segment is projected at USD 695.7 million in 2025, rising to USD 1,302.1 million by 2034, growing at a CAGR of 7.3%, and comprising 23% of total market share.

Top 5 Major Dominant Countries in the Clinic Segment

• United States: Estimated at USD 250.4 million in 2025, holding 36.0% share and 7.2% CAGR, propelled by outpatient oxygen therapy programs.
• China: Valued at USD 120.3 million in 2025, capturing 17.3% share, expanding at 7.6% CAGR due to rapid healthcare facility expansion.
• Germany: At USD 85.6 million, a 12.3% share, and 7.1% CAGR, driven by increased adoption of oxygen concentrators in private clinics.
• Japan: With USD 77.8 million, a 11.2% share, and 7.3% CAGR, demand is supported by growing home and ambulatory clinic care.
• India: Valued at USD 68.2 million, holding 9.8% share and 7.8% CAGR, supported by government focus on rural health access.

Home Care: Home care is the fastest expanding type in many markets. In 2024, home care share derived from end-user segmentation reached over 41.37 % in one data set. Many patients prefer in-home therapy over hospital stays. Over 100,000 portable oxygen concentrator units were sold in the U.S. in 2023. In European and Asia-Pacific markets, rental and lease models are common, with 60–70 % of home units offered on lease. Home care devices must be user-friendly, quiet, and energy efficient. The home care type plays a critical role in Oxygen Therapy Equipment Market Growth and Opportunity sections of market reports.

The Home Care segment is estimated at USD 876.5 million in 2025, projected to reach USD 1,700.4 million by 2034, with a CAGR of 7.5%, representing 29% of the total market share.

Top 5 Major Dominant Countries in the Home Care Segment

• United States: Leads with USD 345.2 million, a 39.4% share, and 7.4% CAGR, owing to rising adoption of portable oxygen concentrators.
• Japan: With USD 142.7 million, holding 16.3% share and 7.6% CAGR, driven by aging populations requiring home oxygen therapy.
• China: Estimated at USD 130.5 million, accounting for 14.9% share, and growing at 7.8% CAGR due to increased awareness of home healthcare.
• Germany: Holds USD 102.8 million, a 11.7% share, with 7.2% CAGR, boosted by demand for long-term oxygen therapy.
• United Kingdom: Valued at USD 95.3 million, capturing 10.9% share, expanding at 7.0% CAGR through technological home care adoption.

Others: The “Others” category includes ambulances, field hospitals, temporary clinics, and disaster relief. These buyers typically adopt portable cylinders, small concentrators, or hybrid systems. In disaster zones or field deployment, 20–30 units of portable equipment may be deployed in a region. This segment often operates on emergency procurement budgets, with flexibility and mobility prioritized. The “Others” type remains small relative to hospital and home care, but it is strategically vital, especially in emerging markets.

The Others segment is valued at USD 246.0 million in 2025, set to reach USD 404.4 million by 2034, growing at a CAGR of 6.0%, contributing 8% to overall market share.

Top 5 Major Dominant Countries in the Others Segment

• United States: Estimated at USD 90.1 million, holding 36.6% share with a 6.0% CAGR, driven by research and institutional use.
• China: With USD 52.8 million, accounting for 21.4% share, and 6.3% CAGR, fueled by innovation and industrial oxygen systems.
• Germany: Valued at USD 31.9 million, a 13.0% share, and 5.8% CAGR, supported by rehabilitation and transport healthcare use.
• Japan: Holds USD 30.6 million, a 12.4% share, expanding at 6.1% CAGR, supported by public health projects.
• India: Estimated at USD 27.5 million, a 11.2% share, growing at 6.4% CAGR, driven by demand from rural healthcare units.

BY APPLICATION

Stationary: Stationary application devices include bulk concentrators, liquid oxygen systems, piped oxygen, and high-capacity oxygen sources. Stationary units accounted for 53.82 % share in 2024 in one segmentation breakdown, while other sources noted 70.2 % share for stationary devices. Many hospital and clinic installations prefer stationary systems for continuous, uninterrupted supply. In large hospital campuses, 5–20 bulk oxygen generators or pipelines are installed per facility. Their economies of scale suit high usage. In developed markets, 60–80 % of new hospital oxygen therapy installs remain stationary. The reliability and durability of stationary systems underpin the bulk of capital equipment orders in Oxygen Therapy Equipment Market Reports.

The Stationary Oxygen Therapy Equipment segment is valued at USD 1,930.6 million in 2025, projected to reach USD 3,408.8 million by 2034, expanding at a CAGR of 6.6% and representing 64% of total share.

Top 5 Major Dominant Countries in the Stationary Application

• United States: Estimated at USD 750.4 million, with 38.8% share and 6.5% CAGR, driven by rising chronic respiratory conditions.
• China: With USD 350.7 million, holding 18.2% share, and 6.8% CAGR, fueled by increasing hospital capacity.
• Germany: Valued at USD 210.9 million, 10.9% share, growing at 6.4% CAGR due to established clinical use.
• Japan: With USD 190.2 million, 9.8% share, and 6.7% CAGR, supported by rising stationary device usage.
• India: Estimated at USD 158.4 million, 8.2% share, and 6.9% CAGR, driven by public healthcare expansion.

Portable: Portable devices include portable oxygen concentrators, portable cylinders, and backpacks. Portable units hold 38.6 % share according to one source. These devices support outpatient mobility, travel, therapy on the go, and use in small home units. In 2024, over 100,000 portable concentrators were reportedly sold in the U.S. Advances in battery technology extended runtime to 6–8 hours for many models. In developed markets, 15–25 models in 2023 offered under 3 kg weight. Growth of telehealth and home monitoring is fueling adoption of portable units. As a result, portable application technology is a frequent highlight in Oxygen Therapy Equipment Market Trends and Market Outlook.

The Portable Oxygen Therapy Equipment segment is estimated at USD 1,097.9 million in 2025, expanding to USD 2,158.9 million by 2034, growing at a CAGR of 7.5% and accounting for 36% of market share.

Top 5 Major Dominant Countries in the Portable Application

• United States: Leads with USD 460.8 million, a 42.0% share, and 7.4% CAGR, owing to adoption of lightweight oxygen concentrators.
• China: Valued at USD 250.6 million, 22.8% share, and 7.7% CAGR, supported by portable healthcare technology growth.
• Japan: Holds USD 160.5 million, 14.6% share, expanding at 7.5% CAGR, driven by elderly care and travel-friendly systems.
• Germany: Estimated at USD 125.7 million, 11.4% share, with 7.2% CAGR, due to growing demand for ambulatory oxygen therapy.
• India: With USD 100.3 million, 9.1% share, and 7.9% CAGR, growth stems from rising home-use demand.

Oxygen Therapy Equipment Market Regional Outlook

Regionally, North America leads with approximately 39.4 %–43.6 % share of the global market, anchored by the U.S. Europe holds second place with 20–25 % share; Asia-Pacific is emerging rapidly, often holding 25–30 % share and exhibiting fastest growth; Middle East & Africa holds smaller share, generally under 10 %, but is rising in infrastructure investment. In Oxygen Therapy Equipment Market Analysis, these regional dynamics are central to defining competitive allocation, product adaptation, and sales strategies across geographies.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America accounts for the largest share 39.4 % in 2024 in one data set, or 43.62 % in another. The U.S. market is the largest within North America, contributing 26.7 % of global share in 2022, and commanding about 30 % share of the global oxygen therapy market in that year. In 2024, North America’s market size was estimated as USD 1,250.5 million, with projection to USD 2,384.0 million later. The well-developed healthcare infrastructure, favorable reimbursement frameworks, and high incidence of respiratory disease drive strong demand. Over 34 million Americans live with chronic lung diseases. The U.S. fixed concentrator share within its concentrator segment is around 46.8 %, and continuous flow technology devices account for 56.03 % in the U.S. market. Hospitals across major U.S. states maintain installation targets of 5–15 units per large facility, while home care leasing programs drive 50–70 % adoption of portable units. The North American region forms a central pillar in Oxygen Therapy Equipment Market Report and Market Forecast analyses.

The North America Oxygen Therapy Equipment Market is valued at USD 1,230.5 million in 2025, projected to reach USD 2,150.8 million by 2034, growing at a CAGR of 6.8%, holding the largest global share.

North America - Major Dominant Countries in the Oxygen Therapy Equipment Market

• United States: Leads with USD 1,005.4 million, holding 81.7% share, and 6.8% CAGR, driven by strong healthcare infrastructure.
• Canada: Valued at USD 128.7 million, 10.5% share, and 6.6% CAGR, due to advanced respiratory care systems.
• Mexico: Holds USD 65.4 million, 5.3% share, growing at 6.9% CAGR, supported by expanding hospital base.
• Cuba: Estimated at USD 17.8 million, 1.4% share, and 6.5% CAGR, driven by public health programs.
• Panama: With USD 13.2 million, 1.1% share, and 6.3% CAGR, fueled by increasing healthcare investments.

EUROPE

Europe occupies a strong second position, with 20–25 % share in most studies. In 2024, Europe’s portion was estimated at USD 865.3 million in one segmentation table. Countries such as Germany, UK, and France lead adoption. In Germany alone, 20–30 % of outpatient respiratory clinics now deploy home oxygen programs. European hospitals often standardize on 5–10 unit stationary concentrator systems per major hospital. In the UK, the number of home oxygen users is estimated at 600,000+, demanding over 150,000 portable and stationary devices. Reimbursement and public healthcare funding drive purchase cycles. Many European units emphasize energy efficiency and noise constraints: about 10–15 models launched in Europe in 2023 featured noise levels under 40 dB. European procurement agencies often bundle remote monitoring features; 12–18 % of device models are configured for connectivity in European markets. Europe is central in the Oxygen Therapy Equipment Market Share and Industry Analysis sections.

The Europe market stands at USD 815.4 million in 2025, projected to reach USD 1,468.2 million by 2034, growing at a CAGR of 6.7%, representing 26.9% of global share.

Europe - Major Dominant Countries in the Oxygen Therapy Equipment Market

• Germany: Leads with USD 225.9 million, 27.7% share, and 6.6% CAGR, driven by advanced medical device use.
• United Kingdom: Valued at USD 180.3 million, 22.1% share, and 6.5% CAGR, supported by national health programs.
• France: Holds USD 140.5 million, 17.2% share, with 6.8% CAGR, due to strong home care segment demand.
• Italy: Estimated at USD 130.8 million, 16.0% share, and 6.7% CAGR, supported by chronic disease management programs.
• Spain: With USD 97.9 million, 12.0% share, growing at 6.9% CAGR, driven by hospital oxygen system modernization.

ASIA-PACIFIC

Asia-Pacific is the fastest emerging region. In 2024, Asia-Pacific oxygen therapy equipment share was estimated at USD 930.7 million in one projection. Some reports show Asia-Pacific capturing 25–30 % of global market share. Countries such as China, India, Japan, and South Korea are driving adoption. In China alone, expansion of home care and respiratory disease prevalence supports deployment of hundreds of thousands of units. In India, less than 5 units per 1,000 population own oxygen therapy devices currently, representing marked growth potential. Asia-Pacific sees heavy adoption of portable devices 40–45 % share locally due to infrastructure constraints. Government programs in China and Japan are subsidizing 30–50 % of costs in rural regions. Asia-Pacific is highlighted in Oxygen Therapy Equipment Market Report as the region with highest growth potential and is central in Oxygen Therapy Equipment Market Forecast and Market Trends.

The Asia market is estimated at USD 704.6 million in 2025, projected to reach USD 1,390.9 million by 2034, expanding at a CAGR of 7.4%, holding 23.3% market share.

Asia - Major Dominant Countries in the Oxygen Therapy Equipment Market

• China: Leads with USD 312.8 million, 44.4% share, and 7.5% CAGR, propelled by government healthcare reforms.
• Japan: Valued at USD 235.1 million, 33.4% share, and 7.3% CAGR, driven by aging population needs.
• India: Holds USD 108.6 million, 15.4% share, growing at 7.7% CAGR, due to expanding rural health infrastructure.
• South Korea: With USD 30.2 million, 4.3% share, and 7.2% CAGR, supported by technology-driven care solutions.
• Indonesia: Estimated at USD 17.9 million, 2.5% share, expanding at 7.6% CAGR, fueled by healthcare modernization.

MIDDLE EAST & AFRICA

Middle East & Africa currently holds the smallest share, often under 10 %. In 2024, one analysis placed Middle East & Africa at USD 244.6 million in market size. Much of the region focuses on import of oxygen equipment, with limited local manufacturing. In Gulf Cooperation Council (GCC) countries, hospital spending supports installation of 5–10 stationary units per large hospital. Countries such as Saudi Arabia, UAE, and South Africa lead regional adoption. Some African nations still struggle to reach 1 unit per 1,000 population penetration. In recent years, 8–12 hospital projects annually in the region add new oxygen therapy capacity. Infrastructure buildout, healthcare modernization, and donor funding (e.g. global health programs) mobilize demand for oxygen equipment in the Middle East & Africa. The region is a key focal region in Oxygen Therapy Equipment Industry Reports and Market Outlook analyses.

The Middle East and Africa market is valued at USD 278.0 million in 2025, projected to reach USD 557.8 million by 2034, growing at a CAGR of 8.0%, contributing 9.2% to global market share.

Middle East and Africa - Major Dominant Countries in the Oxygen Therapy Equipment Market

• Saudi Arabia: Leads with USD 88.7 million, 31.9% share, and 8.1% CAGR, supported by hospital expansions.
• UAE: Valued at USD 54.2 million, 19.5% share, growing at 8.0% CAGR, due to premium healthcare facilities.
• South Africa: Holds USD 49.3 million, 17.7% share, with 7.9% CAGR, driven by chronic respiratory disease prevalence.
• Egypt: Estimated at USD 43.1 million, 15.5% share, and 8.3% CAGR, supported by healthcare reform projects.
• Qatar: With USD 35.0 million, 12.6% share, and 8.2% CAGR, fueled by advanced hospital infrastructure.

List of Top Oxygen Therapy Equipment Market Companies

• Philips Healthcare
• Linde Healthcare
• Becton, Dickinson and Company (BD)
• Taiyo Nippon Sanso Corporation
• Smiths Medical
• Drägerwerk AG & Co. KGaA
• Teleflex Incorporated
• Invacare Corporation
• Chart Industries, Inc.
• Fisher & Paykel Healthcare Corporation Limited
• Inogen, Inc.
• AirSep Corporation
• DeVilbiss Healthcare LLC
• ResMed Inc.
• CAIRE Inc.
• Teijin Pharma Limited
• O2 Concepts LLC
• Precision Medical, Inc.
• Nidek Medical Products, Inc.
• GCE Group AB
• Allied Healthcare Products, Inc.
• Drive DeVilbiss International
• Zadro Health Solutions
• Besco Medical Limited
• Yuwell Medical Equipment & Supply Co., Ltd.
• Beurer GmbH
• 3B Medical, Inc.
• Oxymed
• Longfian Scitech Co., Ltd.
• OxyGo LLC
• O-Two Medical Technologies Inc.
• SysMed (China) Co., Ltd.
• Philips Respironics (Subsidiary of Philips Healthcare)
• Chart SeQual Technologies Inc.
• Heinen + Löwenstein GmbH & Co. KG
• Precision Medical Ltd. (UK)
• Inova Labs Inc.
• Narang Medical Limited (India)
• Allied Medical Limited (India)
• HERSILL S.A. (Spain)
• Weinmann Emergency Medical Technology GmbH & Co. KG
• EmeraMed Ltd.
• Zhangjiagang Besco Medical Co., Ltd.
• Canta Medical Technology Co., Ltd.
• GCE Healthcare (UK)
• Tecno-Gaz S.p.A. (Italy)
• Hersill Medical Equipment (Spain)
• BPR Medical Ltd. (UK)
• Oxyplus Technologies (France)
• Servomex Group Limited (UK)

Top Two Companies with Highest Market Shares

• Philips Healthcare: Philips Healthcare stands as the leading company in the global Oxygen Therapy Equipment Market, holding an estimated 18–21 % share of the overall market in 2024. The company is a dominant force in oxygen concentrators, oxygen delivery systems, and respiratory monitoring technologies. Philips Healthcare’s product portfolio includes advanced stationary and portable oxygen concentrators that are utilized extensively in hospitals, clinics, and home care environments. Its flagship line, Philips Respironics, delivers devices with integrated Bluetooth connectivity, pulse-dose oxygen delivery, and smart tracking systems that help patients monitor oxygen levels in real time. 
• Linde Healthcare: Linde Healthcare, a subsidiary of the Linde Group, ranks as the second-largest participant in the Oxygen Therapy Equipment Market, with an estimated 13–15 % global market share in 2024. The company specializes in providing comprehensive oxygen solutions, including medical oxygen production, liquid oxygen storage, and advanced oxygen delivery systems. 

Investment Analysis and Opportunities

Investment activity in the Oxygen Therapy Equipment Market is accelerating as respiratory disease prevalence increases globally. Approximately 38.42% of oxygen therapy demand is linked to COPD patients, while around 41.37% of total oxygen therapy equipment usage occurs in homecare settings, encouraging healthcare providers and manufacturers to expand infrastructure investments. More than 30% of hospitals worldwide upgraded oxygen delivery infrastructure between 2022 and 2024, focusing on concentrators and liquid oxygen systems capable of delivering 5–10 liters per minute per patient. In the Oxygen Therapy Equipment Market Report, approximately 54–65% of capital equipment investments are allocated to oxygen source equipment such as concentrators and bulk oxygen generators.

The Oxygen Therapy Equipment Market Opportunities are further strengthened by the rapid expansion of portable oxygen therapy solutions. Portable concentrators now represent nearly 38.6% of the total installed oxygen therapy device base, reflecting strong patient demand for mobility and home-based treatment. Healthcare infrastructure initiatives across over 25 developing countries include programs that subsidize up to 30–50% of oxygen therapy device costs to increase accessibility. In addition, more than 15 digital healthcare partnerships between telemedicine providers and oxygen equipment manufacturers were established between 2023 and 2025, integrating oxygen saturation monitoring and device analytics into remote care platforms. These developments are frequently highlighted in the Oxygen Therapy Equipment Market Research Report and Oxygen Therapy Equipment Industry Analysis as key investment drivers.

New Product Development

New product innovation remains a critical growth factor within the Oxygen Therapy Equipment Market Trends landscape. Manufacturers introduced more than 60 new oxygen therapy equipment models globally between 2023 and 2025, with approximately 20–25% of these devices incorporating IoT-based monitoring technology. Modern oxygen concentrators now include integrated oxygen saturation sensors, Bluetooth connectivity, and digital usage tracking systems. In the Oxygen Therapy Equipment Market Insights, nearly 15–20% of new product launches include remote monitoring capabilities that allow healthcare providers to monitor oxygen levels and device performance in real time.

Portable oxygen concentrator innovation is another major development area in the Oxygen Therapy Equipment Market Forecast. Devices weighing less than 3 kilograms now represent nearly 25% of portable oxygen equipment models, enabling easier mobility for patients requiring long-term oxygen therapy. Battery performance has also improved significantly, with several models offering 6–8 hours of continuous operation per charge, compared to 3–4 hours in earlier designs. Additionally, manufacturers are focusing on noise reduction technology, with approximately 30% of newly launched concentrators operating below 40 decibels, improving comfort for homecare patients. These technological advancements are widely discussed in Oxygen Therapy Equipment Market Growth and Oxygen Therapy Equipment Industry Report analyses.

Five Recent Developments (2023–2025)

• In 2024, a major manufacturer introduced a portable oxygen concentrator platform capable of delivering pulse-dose oxygen therapy with efficiency improvements of nearly 18%, supporting extended patient mobility and longer battery life exceeding 7 hours per charge.
• During 2023, a global respiratory equipment company expanded its oxygen therapy manufacturing facility by 35% production capacity, increasing annual output to more than 120,000 oxygen concentrator units for hospitals and homecare providers.
• In 2025, an advanced oxygen monitoring system integrated with oxygen concentrators was launched, capable of tracking more than 12 physiological parameters, including oxygen saturation levels and breathing patterns for remote patient monitoring.
• In 2024, a new dual-mode oxygen concentrator supporting both stationary and portable usage entered the market, providing continuous flow and pulse flow oxygen delivery, and improving device flexibility for nearly 40% of homecare patients requiring mobility.
• In 2023, a manufacturer introduced energy-efficient oxygen concentrator technology capable of reducing electricity consumption by approximately 20% per operational cycle, improving sustainability for hospitals operating oxygen therapy units 24 hours per day.

Report Coverage of Oxygen Therapy Equipment Market

The Oxygen Therapy Equipment Market Report provides extensive coverage of global respiratory care infrastructure, focusing on oxygen concentrators, liquid oxygen systems, compressed oxygen cylinders, and oxygen delivery accessories such as masks and nasal cannulas. The report evaluates market performance across more than 30 countries, examining oxygen therapy equipment adoption rates across hospitals, clinics, and homecare environments. According to the Oxygen Therapy Equipment Market Analysis, oxygen source equipment represents approximately 54–65% of the total product segment share, while oxygen delivery accessories account for nearly 30–35% of equipment utilization across healthcare facilities.

The Oxygen Therapy Equipment Market Research Report also analyzes demand patterns across stationary and portable device segments. Stationary oxygen systems account for roughly 53–70% of equipment installations in hospital settings, while portable oxygen concentrators represent nearly 38.6% of the global device base, driven by rising demand for home healthcare and ambulatory oxygen therapy solutions. The report evaluates technology adoption across more than 50 manufacturers globally, examining product innovations including IoT-enabled oxygen monitoring, lightweight portable concentrators, and digital respiratory therapy platforms. In addition, the Oxygen Therapy Equipment Market Outlook includes regional insights covering North America, Europe, Asia-Pacific, and Middle East & Africa, where respiratory disease prevalence affects more than 200 million patients worldwide, highlighting the expanding role of oxygen therapy equipment across modern healthcare systems.

Oxygen Therapy Equipment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 3240.48 Million in 2026
Market Size Value By	USD 5957.45 Million by 2035
Growth Rate	CAGR of 7% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Staionary Portable By Application : Hospital Clinic Home Care Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample